DQIP Study

DQIP - Data-driven Quality Improvement in Primary Care

The research program, funded by the Chief Scientist Office (The Scottish Government), developed and evaluated an intervention to improve drug therapy safety in outpatient care. The first step was to develop indicators to identify "high risk prescriptions" in a consensus process, which were then implemented in a web-based IT tool.

The tool enables GP practices to identify patients with high-risk prescriptions of antithrombotics (e.g. ASA, phenprocoumon) and/or non-steroidal anti-inflammatory drugs (NSAIDs, such as ibuprofen or diclofenac) who have an increased risk of adverse drug reactions (gastrointestinal bleeding, acute renal failure, heart failure). In addition, the DQIP intervention included an "Educational outreach visit (EOV)", i.e. a one-hour educational event conducted by a pharmacist in GP practices, as well as financial incentives for GPs (€20 per medication analysis performed by the GP on a patient with a high-risk prescription identified by the IT tool). The intervention was evaluated in a cluster-randomized study in 34 GP practices and the results were published in the New England Journal of Medicine in 2016.